EGFR-targeted photoimmunotherapy and its association with the immune microenvironment in locoregional recurrent head and neck squamous cell carcinoma

BackgroundEpidermal growth factor receptor (EGFR)-targeted photoimmunotherapy using cetuximab sarotalocan sodium (RM-1929) represents a novel therapeutic modality that induces selective tumor cell death and may influence the tumor immune microenvironment (TIME) in head and neck squamous cell carcino...

Descripció completa

Dades bibliogràfiques

Autors principals:	Koichi Yoshizawa, Takahiro Tsujikawa, Peesit Leelasawatsuk, Mai Mohamed Bedeir, Yuna van der Aar, Tim de Martines, Saya Shibata, Hiroshi Ogi, Ryuhei Okada, Alisa Kimura, Hiroki Morimoto, Sumiyo Saburi, Shigeyuki Mukudai, Hikaru Nagao, Aya Miyagawa-Hayashino, Eiichi Konishi, Kyoko Itoh, Takahiro Asakage, Shigeru Hirano
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-04-01
Col·lecció:	Frontiers in Immunology
Matèries:	EGFR head and neck squamous cell carcinoma immune microenvironment locoregional recurrence photoimmunotherapy
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1814205/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!